Papadomanolakis-Pakis Nicholas, Haroutounian Simon, Sørensen Johan K, Runge Charlotte, Brix Lone D, Christiansen Christian F, Nikolajsen Lone
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Department of Anaesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark.
Pain Rep. 2025 Sep 3;10(5):e1329. doi: 10.1097/PR9.0000000000001329. eCollection 2025 Oct.
Moderate-to-severe acute postsurgical pain (APSP) is experienced by approximately 30% of surgical patients.
To improve early APSP management, we developed 2 pragmatic and generalizable point-of-care risk tools to preoperatively predict moderate-to-severe and severe APSP in the postanaesthesia care unit (PACU).
This was a multicenter prospective cohort study of adult patients undergoing elective surgical procedures between May 2021 and May 2023. Candidate predictors were preidentified. Logistic regression was used to develop the models. Internal validation was conducted with bootstrap resampling. Model performance was assessed by discrimination and calibration. Decision curve analysis was conducted to evaluate clinical utility of the models.
The final cohort included 1380 patients; 45.1% experienced moderate-to-severe APSP and 12.4% experienced severe APSP in the PACU. Predictors retained in the final models independently associated with increased risk of both moderate-to-severe and severe pain included younger age, female sex, preoperative pain in the surgical area, preoperative opioid use, and longer expected surgery duration. Orthopedic surgery and regional anesthesia were associated with decreased risk of both outcomes. In addition, minimally invasive surgery was associated with increased risk of moderate-to-severe APSP, and other preoperative pain was associated with increased risk of severe APSP. Optimism-corrected area under the receiver operating characteristic curves were 0.75 and 0.72 for moderate-to-severe and severe APSP models, respectively. Both models demonstrated good calibration and beneficial clinical utility.
Our models developed using point-of-care data on a heterogeneous surgery sample demonstrated acceptable performance and clinical utility for early APSP prediction. External validation is needed before implementation.
约30%的手术患者会经历中重度急性术后疼痛(APSP)。
为改善早期APSP管理,我们开发了两种实用且可推广的床旁风险工具,用于术前预测麻醉后护理单元(PACU)中的中重度和重度APSP。
这是一项对2021年5月至2023年5月期间接受择期手术的成年患者进行的多中心前瞻性队列研究。预先确定了候选预测因素。使用逻辑回归来开发模型。通过自助重采样进行内部验证。通过辨别力和校准来评估模型性能。进行决策曲线分析以评估模型的临床实用性。
最终队列包括1380名患者;45.1%的患者在PACU中经历了中重度APSP,12.4%的患者经历了重度APSP。最终模型中保留的与中重度和重度疼痛风险增加独立相关的预测因素包括年龄较小、女性、手术区域术前疼痛、术前使用阿片类药物以及预期手术持续时间较长。骨科手术和区域麻醉与这两种结果的风险降低相关。此外,微创手术与中重度APSP风险增加相关,其他术前疼痛与重度APSP风险增加相关。中重度和重度APSP模型的乐观校正受试者操作特征曲线下面积分别为0.75和0.72。两个模型均显示出良好的校准和有益的临床实用性。
我们使用异质手术样本的床旁数据开发的模型在早期APSP预测方面表现出可接受的性能和临床实用性。实施前需要进行外部验证。